Global Non-small Cell Lung Cancer Market 2014-2018

TechNavio Insights

USA – CANADA – UK – CHINA – INDIA

Market Overview: Non-small Cell Lung Cancer

About Non-small Cell Lung Cancer • Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation.

• Lung cancer is the leading cause of cancer deaths worldwide, and the incidence of lung cancer is increasing significantly.

• Lung cancer is the common cause of mortality and morbidity not only in developed countries but also in developing countries.

• One of the most common types of lung cancer is non-small cell lung cancer and it grows and spreads quite slowly.

• Smoking is considered as a major cause of lung cancer, although lung cancer also occurs in non-smokers.

• There are three main types of non-small cell lung cancer: squamous cell (epidermoid) carcinoma, adenocarcinoma, and large cell (undifferentiated) carcinoma.

• Some of the common symptoms associated with non-small cell lung cancer are chest pain, a cough that does not go away, coughing up blood, fatigue, loss of appetite, losing weight without trying, shortness of breath, and wheezing.

• TechNavio's analysts forecast the Global Non-small Cell Lung Cancer market to grow at a CAGR of 3.62 percent over the period 2013-2018.

USA – CANADA – UK – CHINA – INDIA

Covered in This Report

• This report covers the present scenario and the growth prospects of the Global Non-small Cell Lung Cancer market for the period 2014-2018.

• To calculate the market size, the report considers the revenue generated through various therapies adopted for the treatment of non-small cell lung cancer, including

• Biologics • Small Molecules

• TechNavio's report, the Global Non-small Cell Lung Cancer Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.

• The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Non-small Cell Lung Cancer market landscape and its growth prospects in the coming years.

• The report includes a discussion of the key vendors operating in this market.

USA – CANADA – UK – CHINA – INDIA

Key Regions

Americas

EMEA

APAC

USA – CANADA – UK – CHINA – INDIA

Key Vendors

Key Vendors• AstraZeneca• Celgene• Eli Lilly• F. Hoffmann-La Roche• Pfizer

Other Prominent Vendors• Aetna• Boehringer Ingelheim• Celldex• Eisai• GlaxoSmithKline• IMClone• Merck Serono• Novartis• Qiagen• OncoGenex

USA – CANADA – UK – CHINA – INDIA

Market Drivers, Challenges and Trends

Guest BloggersDriver• High Unmet Needs.• For a full, detailed list, view our report.

Challenge

• High Cost of Therapy.• For a full, detailed list, view our report.

Trend

• Availability of Personalized Medicine.• For a full, detailed list, view our report.

A detailed analysis of each market driver, challenge and trend is available in

our report:

Global Non-small Cell Lung Cancer Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

Key Questions

Questions Answered in Our Report• What will the market size be in 2018 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key

vendors?• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

USA – CANADA – UK – CHINA – INDIA

View Our Report

Global Non-small Cell Lung Cancer Market 2014-2018

View Report >>

TechNavio's report, Global Non-small Cell Lung Cancer Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.

Published on: September 10, 2014 | 90 Pages | SKU: IRTNTR4123

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

More than 2500 Reports in Niche Domains

by 200 Analysts located Globally

In Operation for More than

10 Years with Offices in London, Chicago, Toronto, Beijing &

Bangalore

Cover More than 500 Emerging New

Technologies across 80 Countries in US, EMEA &

APAC Regions

Reports Cover : Market Scenarios, Vendor landscape & Industry Road Maps.Option to Customize Report & Access to Analysts on every Report Purchase.

About Us

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

Mail us at: enquiry@technavio.com

You can visit us at:www.technavio.com

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of

or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION